Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients

NCT00381368 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Ibandronic acid

Sponsor

University of Turku

Collaborators

[object Object]